Your Source for Dermatitis Information

 

Program
Title
Time
Price
MA-0616M
Advances in Treatment of Herpes Zoster Infection
120 min
$289.00

Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD

The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.
MA-1012M
Management of Herpes Zoster
120 min.
$289.00

Myron J. Levin, MD; Larry Gelb, MD; Michael Oxman, MD; Allyn Bandell, PharmD; Peter Watson, MD; Wayne Gray, PhD

A panel of leading dermatologists, infectious disease physicians and managed care professionals will apply disease management principles to the diagnosis and treatment of Herpes Zoster.

MB-0302M
Advances in Treatment of Herpes Zoster
120 min.
$289.00

Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD

The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.

MC-0228M
Advances in the Treatment of Genital Herpes  
90 min
$249.00

Lawrence Stanberry, MD, PhD; Michael V. Reitano, MD; Stephen L. Sacks, MD, FRCPC; Larry Corey, MD; Charles Ebel

Asymptomatic Shedding and Transmission; Current use of Acyclovir for the Therapy of Genital Herpes;Treatment with vaccines; Treatment and suppression of recurrent Herpes Simplex: Famcyclovir; General clinical manifestations; What the patient's expectations are.

MC-0516M
Management of Melanoma
90 min.
$249.00

Antonio Buzaid, MD; Merick Ross, MD

Adjuvant Therapy: Interferon and New Advances in Patients with Advanced Diseases; Diagnosis and Prognosis of Primary Melanoma.
MD-0408M
Recent Advances in Treatment of Cutaneous Fungal Infections (Onychomycosis)
90 min.
$249.00

Norman Guzick, MD; Phoebe Rich, MD - John Wolf, MD; H. Irving Katz, MD

Psychosocial Ramifications and Epidemiology; Diagnosis and Differential; Current Treatment Strategies for Onychomycosis; Safety Concerns Regarding Drug Interaction Potential and Liver Metabolism
ME-0526N
Pressure Ulcers: Prevention & Treatment      
60 min.
$209.00

Mary Y. Sieggreen, RN, CS, CNP, CVN, MSN; Maria Palleschi, MSN, RN, CCRN; JoAnn Maklebust, MSN, RN, CS, NP.

Describes the most common pressure ulcer risk factors and the wound healing process; Identify methods for pressure ulcer prevention and treatment.
ME-0618M
Antifungal Therapy Beyond the Year 2000   
150 min.
  $309.00

Boni E. Elewski, MD; Hideoki Ogawa; David T. Roberts; Bardur Sigurgeirsson; Christa de Cuyper; D. O'Sullivan; Irving Katz, MD; E.G.V. Evans, PhD, FRCPath; R.J. Hay, DM, FRCPath

Understand the newest treatment regimens in onychomycosis therapy. Discuss the safety profile of antimycotics including side effects and drug interactions. Recognize the challenges in the management of onychomycosis. Discuss the long-term outcome of onychomycosis treatment.


This healthcare portal website has been created as a source of objective and credible health and medical information for healthcare professionals and consumers and does not endorse any specific product, service or organization. MEDIVISION does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professional.
COPYRIGHT © MEDIVISION, 2011